From magic bullets to designed multiple ligands

被引:655
作者
Morphy, R [1 ]
Kay, C [1 ]
Rankovic, Z [1 ]
机构
[1] Organon Labs, Dept Med Chem, Newhouse ML1 5SH, Lanark, Scotland
关键词
D O I
10.1016/S1359-6446(04)03163-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Increasingly, it is being recognised that a balanced modulation of several targets can provide a superior therapeutic effect and side effect profile compared to the action of a selective ligand. Rational approaches in which structural features from selective ligands are combined have produced designed multiple ligands that span a wide variety of targets and target classes. A key challenge in the design of multiple ligands is attaining a balanced activity at each target of interest while simultaneously achieving a wider selectivity and a suitable pharmacokinetic profile. An analysis of literature examples reveals trends and insights that might help medicinal chemists discover the next generation of these types of compounds.
引用
收藏
页码:641 / 651
页数:11
相关论文
共 54 条
[1]   Amphipathic 3-phenyl-7-propylbenziscoxazoles;: human PPaR γ, δ and α agonists [J].
Adams, AD ;
Yuen, W ;
Hu, Z ;
Santini, C ;
Jones, AB ;
MacNaul, KL ;
Berger, JP ;
Doebber, TW ;
Moller, DE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (05) :931-935
[2]   Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans [J].
Ananthan, S ;
Kezar, HS ;
Carter, RL ;
Saini, SK ;
Rice, KC ;
Wells, JL ;
Davis, P ;
Xu, H ;
Dersch, CM ;
Bilsky, EJ ;
Porreca, F ;
Rothman, RB .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (18) :3527-3538
[3]   Actions of tramadol, its enantiomers and principal metabolite, O-desmethyltramadol, on serotonin (5-HT) efflux and uptake in the rat dorsal raphe nucleus [J].
Bamigbade, TA ;
Davidson, C ;
Langford, RM ;
Stamford, JA .
BRITISH JOURNAL OF ANAESTHESIA, 1997, 79 (03) :352-356
[4]   Synthesis and activity of a new methoxytetrahydropyran derivative as dual cyclooxygenase-2/5-lipoxygenase inhibitor [J].
Barbey, S ;
Goossens, L ;
Taverne, T ;
Cornet, J ;
Choesmel, V ;
Rouaud, C ;
Gimeno, G ;
Yannic-Arnoult, S ;
Michaux, C ;
Charlier, C ;
Houssin, R ;
Hénichart, JP .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (05) :779-782
[5]   Synthesis and NK1/NK2 binding activities of a series of diacyl-substituted 2-arylpiperazines [J].
Blythin, DJ ;
Chen, X ;
Piwinski, JJ ;
Shih, NY ;
Shue, HJ ;
Anthes, JC ;
McPhail, AT .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (21) :3161-3165
[6]   Systematic discovery of multicomponent therapeutics [J].
Borisy, AA ;
Elliott, PJ ;
Hurst, NW ;
Lee, MS ;
Lehár, J ;
Price, ER ;
Serbedzija, G ;
Zimmermann, GR ;
Foley, MA ;
Stockwell, BR ;
Keith, CT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) :7977-7982
[7]   Design and synthesis of a novel synthetic NAPAP-pentasaccharide conjugate displaying a dual antithrombotic action [J].
Buijsman, RC ;
Basten, JEM ;
van Dinther, TG ;
van der Marel, GA ;
van Boeckel, CAA ;
van Boom, JH .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (14) :2013-2018
[8]   Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents [J].
Campiani, G ;
Butini, S ;
Fattorusso, C ;
Catalanotti, B ;
Gemma, S ;
Nacci, V ;
Morelli, E ;
Cagnotto, A ;
Mereghetti, I ;
Mennini, T ;
Carli, M ;
Minetti, P ;
Di Cesare, MA ;
Mastroianni, D ;
Scafetta, N ;
Galletti, B ;
Stasi, MA ;
Castorina, M ;
Pacifici, L ;
Vertechy, M ;
Di Serio, S ;
Ghirardi, O ;
Tinti, O ;
Carminati, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (01) :143-157
[9]  
Conway JG, 2001, J PHARMACOL EXP THER, V298, P900
[10]   DUAL INHIBITION OF NEUTRAL ENDOPEPTIDASE AND ANGIOTENSIN-CONVERTING ENZYME BY N-PHOSPHONOMETHYL AND N-CARBOXYALKYL DIPEPTIDES [J].
DELOMBAERT, S ;
TAN, J ;
STAMFORD, LJ ;
SAKANE, Y ;
BERRY, C ;
GHAI, RD .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (22) :2715-2720